ZS Pharma
508 Wrangler Drive
Suite 100
Coppell
Texas
75019
United States
Tel: 650-458-4100
Fax: 650-458-0084
Website: http://www.zspharma.com/
62 articles with ZS Pharma
-
Bay Area's Allakos Taps Former ZS Pharma CEO As New Leader
8/15/2017
-
ZS Pharma Selects TikaMobile As Their Mobile Intelligence And Analytics Platform
12/22/2016
-
2 Biotechs Investors Should Pick Up Before Key PDUFA Dates
5/5/2016
-
ZS Pharma Announces New Employment Inducement Grants
12/9/2015
-
ZS Pharma Announces New Employment Inducement Grants
11/11/2015
-
ZS Pharma Announces Positive Interim Results From A Long-Term Safety Study Of ZS-9
11/9/2015
-
AstraZeneca PLC Coughs Up $2.7 Billion for Bay Area's ZS Pharma and its Hyperkalemia Treatment
11/9/2015
-
ZS Pharma Announces Upcoming Poster Presentation Of Interim Results From Its Long-Term Safety Study Of ZS-9
10/19/2015
-
Bay Area ZS Pharma Jumps on Merger Talks, Actelion Stock Drops
9/18/2015
-
Europe’s Biggest Biotech, Actelion, Offering $2.5 Billion to Buy U.S.-Based ZS Pharma
9/14/2015
-
ZS Pharma Reports Second Quarter 2015 Financial Results And Provides Corporate Update
8/7/2015
-
ZS Pharma Announces FDA Acceptance Of ZS-9 New Drug Application
7/30/2015
-
ZS Pharma Names Jeffrey Farrow As Chief Financial Officer
6/16/2015
-
ZS Pharma Announces Participation At Upcoming Investor Conferences
5/28/2015
-
ZS Pharma Submits New Drug Application To FDA For ZS-9 For The Treatment Of Hyperkalemia
5/27/2015
-
ZS Pharma Announces Multiple ZS-9 Data Presentations At Upcoming Medical Meetings
5/12/2015
-
ZS Pharma To Present At Bank of America Merrill Lynch 2015 Health Care Conference
5/6/2015
-
ZS Pharma Appoints Kimberly Popovits To Board Of Directors
5/6/2015
-
ZS Pharma Reports First Quarter 2015 Financial Results And Provides ZS-9 Program Update
4/27/2015
-
ZS Pharma Announces Publications In Peer-Reviewed Medical Journals
4/16/2015